-
Opinion: Regulatory Flexibility Can Accelerate Rare Disease Drug Development
17 Jun 2024 06:55 GMT
… presenting several obstacles to straightforward drug development.
The main issue … clinical Trials Advancing Rare disease Therapeutics (START) pilot program, which … research organization that supports biotech and pharma companies to develop innovative, often …
-
RNA Based Therapeutic Market Projected to Reach $4.35 Billion by 2030 with a CAGR of 17.6%
17 Jun 2024 06:27 GMT
… development.
Collaborations and Partnerships
Pharma-Biotech Collaborations: Strategic alliances for … , Alnylam Pharmaceuticals, Inc., one of the leading RNAi therapeutics company, announced … that the U.S. Food and Drug …
-
Machine Learning: A Potential Therapeutic Tool to Facilitate Neonatal Therapeutic Decision Making.
17 Jun 2024 05:03 GMT
… and Evaluation of Innovative Drug, School of Pharmaceutical Sciences, Cheeloo College … and Evaluation of Innovative Drug, School of Pharmaceutical Sciences, Cheeloo College … and Evaluation of Innovative Drug, School of Pharmaceutical Sciences, Cheeloo College …
-
Variation of adverse drug events in different settings in Africa: a systematic review.
17 Jun 2024 05:03 GMT
Adverse drug events (ADEs) represent challenges affecting Africa’s healthcare systems owing to the increased healthcare expenditure and negative health outcomes of ADEs.
We aimed to systematically review published studies on ADEs and synthesize the …
-
Erythropoietin Drugs Market Booming with 5.7% CAGR | AMR
17 Jun 2024 06:43 GMT
… of EPO therapeutics boost growth of the erythropoietin drugs market.
Rise … Sciences Ltd.
Teva Pharmaceutical Industries Ltd.
Intas Pharmaceuticals
Ranbaxy Laboratories Ltd. … professional corporate relations with various companies and this helps us …
-
Arimoclomol citrate ER by Zevra Therapeutics for Niemann-Pick Disease Type C: Likelihood of Approval
17 Jun 2024 07:27 GMT
… data. Attributes of the drug, company and its clinical trials … shock protein 70.
The drug candidate was also under development … s a rare disease therapeutics company that offers discovery and development … on GlobalData’s Pharmaceutical Intelligence Center.
-
'Pharmacy deserts' shift care landscape
17 Jun 2024 08:17 GMT
… bigger populations.
Pharmacy as a care location
Drugstores have become bigger … more than 24,000 independent pharmacies. But drugstores routinely close because they … estimate conservative. Of those pharmacies, 54% were independent drugstores, an AP analysis …
-
World’s first weekly insulin injection coming to Canada in 2 weeks, manufacturer says
17 Jun 2024 08:15 GMT
… week instead of daily, drug manufacturer Novo Nordisk announced on … starting June 30, the company told The Canadian Press … week instead of daily, drug manufacturer Novo Nordisk announced on … Its endocrinology and metabolic drugs advisory committee concluded in …
-
LONDON BRIEFING: Astra gets US drug approval; Ascential trades in line
17 Jun 2024 07:01 GMT
… the chemicals and veterinary sectors, better touring … report added.
----------
Manufacturers are seeing signs of … lymphoma.
----------
Pharmaceutical company Hikma Pharmaceuticals said it has … critical care therapies provider Xellia Pharmaceuticals to acquire …
-
Obicetrapib calcium by NewAmsterdam Pharma Company for Alzheimer’s Disease: Likelihood of Approval
17 Jun 2024 07:27 GMT
… daily formulation. The drug candidate acts by targeting … Pharma Company overview
NewAmsterdam Pharma Company (NAP), a clinical stage biotechnology company focused … on the research and development of transformative therapies …